Cisplatin-linked phosphonates in the treatment of the transplantable osteosarcoma in vitro and in vivo.
Klenner
T
T
Institute of Toxicology and Chemotherapy, German Cancer Research Center, Heidelberg.
Valenzuela-Paz
P
P
Keppler
B K
BK
Angres
G
G
Scherf
H R
HR
Wingen
F
F
Amelung
F
F
Schmähl
D
D
D000818:Animals; D000970:Antineoplastic Agents / Q000737:chemistry / Q000627:therapeutic use; D002945:Cisplatin / Q000494:pharmacology* / Q000627:therapeutic use; D004354:Drug Screening Assays, Antitumor; D009368:Neoplasm Transplantation; D009943:Organophosphorus Compounds / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use; D009944:Organoplatinum Compounds / Q000737:chemistry / Q000494:pharmacology* / Q000627:therapeutic use; D012516:Osteosarcoma / Q000188:drug therapy* / Q000473:pathology; D051381:Rats; D014407:Tumor Cells, Cultured / Q000187:drug effects
D000970:Antineoplastic Agents; D009943:Organophosphorus Compounds; D009944:Organoplatinum Compounds; C064516:aminotris(methylenephosphonato)diamminoplatinum (II); D002945:Cisplatin